Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 25.52 billion as of March 9, 2026. Its market cap has decreased by -41.54% in one year.

Market Cap

25.52B

Enterprise Value

24.74B

Revenue

35.83M

Ranking

n/a

PE Ratio

n/a

Stock Price

151.50

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 25.52B, an increase of 494.24%. That is a compound annual growth rate of 18.22%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	26.36B	-19.54%
Dec 31, 2025	32.77B	-22.40%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Oneness Biotech	26.27B
Polaris Group	23.58B
Sunmax Biotechnology	21.21B
Lin BioScience	33.05B
Pell Bio-Med Technology	36.42B
EirGenix	18.10B
TaiMed Biologics	14.62B
AP Biosciences	14.46B

Market Cap Rankings